Keyphrases
Osteoporosis
100%
Estrogen
75%
Fracture Risk
69%
Postmenopausal Women
66%
Bone Mineral Density
65%
Bone Loss
59%
Senescent Cells
49%
Osteoblast
43%
Aging
38%
Bone Resorption
36%
Sex Steroids
34%
Bone Turnover
34%
Estrogen Receptor
32%
Cellular Senescence
31%
Senescence
31%
Bone Strength
30%
Age-related Bone Loss
28%
Bone Turnover Markers
27%
Peripheral Quantitative Computed Tomography (pQCT)
27%
Bone Metabolism
27%
Bone Formation
27%
Population-based Study
26%
Cortical Bone
26%
Hip Fracture
25%
Osteoclast
25%
Intact Parathyroid Hormone (iPTH)
25%
Bone Microarchitecture
24%
Estrogen Deficiency
24%
Osteocalcin
23%
Senolytics
23%
Testosterone
23%
Volumetric Bone Mineral Density (vBMD)
22%
Osteoporotic Fractures
22%
Bone Mass
20%
Osteoprotegerin
20%
Elderly People
19%
Quantitative Computed Tomography
19%
Androgens
19%
Age-related
19%
Areal Bone Mineral Density (aBMD)
19%
Sclerostin
18%
Gene Expression
18%
Confidence Interval
17%
Human Osteosarcoma Cells
16%
Trabecular Bone
16%
Femoral Neck
16%
Osteocyte
16%
Computed Tomography
15%
Elderly Women
15%
Dual-energy X-ray Absorptiometry
15%
Medicine and Dentistry
Osteolysis
88%
Osteoporosis
79%
Bone Density
69%
Postmenopause
47%
Osteoblast
40%
Bone Turnover
35%
Quantitative Computed Tomography
33%
Cellular Senescence
30%
Sex Hormone
29%
Bone Remodeling
29%
Cancellous Bone
27%
Diseases
27%
Bone Strength
26%
Bone Mass
25%
Cortical Bone
25%
Fragility Fracture
23%
Parathyroid Hormone
21%
Osteocalcin
21%
Ossification
21%
Androgen
18%
Skeleton
18%
Isotopes of Calcium
17%
Estrogen Deficiency
17%
Hip Fracture
17%
Messenger RNA
17%
Spine Fracture
16%
Forearm Fracture
16%
Osteoprotegerin
15%
Maturity Onset Diabetes of the Young
14%
Femoral Neck
14%
Diethylstilbestrol
13%
Osteocyte
13%
Finite Element Analysis
13%
In Vitro
12%
Standardized Incidence Ratio
12%
Osteoplasty
11%
Estrogen Receptor
11%
Osteoclast Differentiation Factor
11%
Dual-Energy X-Ray Absorptiometry
11%
Cohort Effect
11%
Computer Assisted Tomography
11%
Primary Hyperparathyroidism
11%
Adipocyte
11%
Bone Structure
10%
Hazard Ratio
10%
Gene Expression
10%
Cohort Analysis
10%
Estrogen Therapy
9%
Endothelial Progenitor Cell
9%
Receptor
9%
Biochemistry, Genetics and Molecular Biology
Osteolysis
82%
Osteoblast
66%
Bone Density
53%
Bone Remodeling
38%
Postmenopause
33%
Bone Turnover
32%
Estrogen Receptor
27%
Ossification
26%
Bone Mass
24%
Computer Assisted Tomography
22%
Osteoclast
21%
Messenger RNA
20%
Stromal Cell
18%
Gene Expression
17%
Sclerostin
16%
Osteocyte
16%
Osteocalcin
16%
Osteoprotegerin
16%
Parathyroid Hormone
15%
Prevalence
14%
Cytokine
13%
RANKL
13%
Estradiol
12%
Osteoclastogenesis
11%
Adipocyte
10%
Isoform
10%
Clinical Trial
10%
CD34
10%
Bone Strength
10%
Alkaline Phosphatase
9%
Endothelial Progenitor Cell
8%
Cancer Growth Factor
8%
Quercetin
8%
Dasatinib
8%
Binding Protein
8%
Mouse Model
7%
Precursor
7%
Wnt Signaling Pathway
6%
Progenitor Cell
6%
Normal Human
6%
Orphan Receptor
6%
Vitamin D
6%
RNA Sequence
6%
Interleukin-1
6%
Leptin
5%
P16
5%
X Ray
5%
CD133
5%
MicroRNA
5%
Macrophage
5%